This event has ended. Visit the official site or create your own event on Sched.
AU-EU Summit 17-18 February 2022: A Science Agenda

The AERAP Africa-Europe Science Collaboration Platform will organise side events at the AU-EU Summit on 14-18 February 2022. The purpose of the meeting will be to promote awareness of the contribution of collaborative research and development as a critical aspect of EU-Africa relations and collaborations, in particular in addressing global challenges together.

To join this event please register here.

Back To Schedule
Thursday, February 17 • 12:00 - 13:30
(REF 171200) Innovating and promoting R&D addressing priority needs in antimicrobial resistance - Convened by the Global AMR R&D Hub

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Feedback form is now closed.

Innovating and promoting R&D addressing priority needs in antimicrobial resistance

Antimicrobial resistance (AMR) continues to be one of the major global challenges of our times, representing an ever-increasing threat to human, animal, and environmental health, and an ever-present and growing socio-economic burden.Recent work has shown that AMR is a leading cause of death worldwide, directly attributable to an estimated 1.27 million deaths in 2019, a figure that is similar to the global death toll of HIV and malaria combined. Although AMR is a complex and dynamic multi-disciplinary and multi-sectoral challenge that transcends geographical boundaries, the burden of its impact is felt disproportionately in low and middle-income countries with reported rates of death attributable to resistance highest in the Sub-Saharan region of Africa.
Given the urgency of the situation, there is a need for coordinated efforts in AMR across the value chain from research and development (R&D) efforts to the incentives being implemented globally that aim to improve the functioning of markets responsible for the development and distribution of priority health technologies for addressing AMR. Realising the critical nature of AMR has invigorated international and national efforts at the community, organisational and governmental level to fund R&D in the AMR field, especially over the last decade. Investments in R&D are crucial for developing solutions in terms of effective interventions and products resulting in the prevention, containment or reduction of AMR. However, the translation of this funding into outcomes and benefits for those with the highest priority needs remains challenging.
 The Global AMR R&D Hub aims to further improve the coordination of international efforts and initiatives to tackle AMR while further increasing investments into R&D for AMR. In order to promote the development of health technologies and strategies addressing AMR, resources need to be employed even more effectively than at present.
This session aims to gain insight into the country-specific, economic, social and environmental factors facing AMR-related R&D within Africa and Europe, and the translation of investments into tools, products and policies that could meaningfully impact AMR.
We explore development and access to priority antimicrobials gaining a wide variety of perspectives from researchers, clinicians, policymakers and other key opinion leaders, sharing lessons learned and exploring the potential for synergies for translating AMR R&D into impact.

Moderation/Chair: Representative of the Global AMR R&D Hub

avatar for Declan Kirrane

Declan Kirrane

Chair Science Summit UNGA77, ISC
Declan Kirrane is the Founder and Managing Director of ISC Intelligence in Science, the chairman and managing director of the science Summit at the United Nations General assembly, and co-founder of Medicines for Future (MAF). He has over 25 years of experience as a global senior... Read More →
avatar for Lesley Ogilvie

Lesley Ogilvie

Senior Scientific Programme Officer, Global AMR R&D Hub
Lesley is a Scientific Programme Officer at the Global AMR R&D Hub, Berlin, a global partnership focussed on addressing challenges and improving coordination and collaboration in global AMR R&D using a One Health approach. She has over ten years-experience working in academia as a... Read More →
avatar for Daniel Waruingi

Daniel Waruingi

Co-founder and Head of Programs, Students Against Superbugs Africa
Daniel Waruingi is the co-founder and Head of Programs at Students Against Superbugs Africa (SAS Africa) and is the brain behind SAS Africa's dream and vision. He supports the planning and coordination of programs. He also ensures the implementation of policies and practices and oversees strategy development in the organization. He is passionate about policymaking and bringing AMR t... Read More →
avatar for Yann Ferrisse

Yann Ferrisse

Business Development Head, Global Antibiotic Research & Development Partnership (GARDP)
Yann Ferrisse joined GARDP in January 2018 and is leading the Business Development activities of GARDP. Since mid-2020, Yann is working on all GARDP market access strategies related to GARDP’s products. He brings to GARDP a combination of business and entrepreneurial experience... Read More →
avatar for Moodley, Arshnee

Moodley, Arshnee

AMR Team Leader, International Livestock Research Institute, Nairobi Kenya
Arshnee is a microbiologist with many years of experience in AMR. She leads the CGIAR Antimicrobial Resistance Hub that focuses on mitigating AMR risks associated with agriculture in LMICs through research to address knowledge gaps and strengthening partnerships.
avatar for Yewande Alimi

Yewande Alimi

Antimicrobial Resistance (AMR) and One Health Program Coordinator, Africa CDC
Dr Yewande Alimi MPH, FRSPH, is the Antimicrobial Resistance (AMR) and One Health Program Coordinator at Africa Centres for Disease Control and Prevention, and co-lead for the Africa Union Task force on AMR. She currently leads the Infection Prevention and Control (IPC) Section for... Read More →
avatar for Abdoulaye Djimde

Abdoulaye Djimde

Founding President, African Association for research and control of AntiMicrobial Resistance
Abdoulaye Djimde received a Pharmacy Doctoral degree from Ecole Nationale de Medecine et de Pharmacie of Bamako, Mali in 1988, a Fellowship at the US National Institutes in 1996, a PhD in Microbiology and Immunology at the University of Maryland, Baltimore, Maryland, USA which he... Read More →
avatar for Ghada Zoubiane

Ghada Zoubiane

Head of Partnerships and Stakeholders Engagement, International Centre for AMR solutions
Ghada is the Head of Partnership and Stakeholder Engagement at ICARS. In her role, she is shaping and delivering on ICARS’ mission, bridging the gap between evidence and practice, and working in close partnership with low- and middle-income countries. She is developing collaborations... Read More →
avatar for Ralf Sudbrak

Ralf Sudbrak

Interim Secretariat Lead, Global AMR R&D Hub
Dr. Ralf Sudbrak is Senior Scientific Programme Officer at the Global AMR R&D Hub in Berlin. The main goal of the HUB is to promote high-level coordination among governments and upstream funders from different world regions, in order to better align national and international R&D... Read More →

Thursday February 17, 2022 12:00 - 13:30 CET